Praxis Precision Medicines, Inc. PRAX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$326.53M-7.7% | -$303.27M-11.1% | -$273.04M-8.8% | -$251.01M-18.1% | -$212.56M-16.3% | ||
| $132K-5.7% | $140K-11.9% | $159K-31.5% | $232K-20.8% | $293K-18.2% | ||
| $42.27M+24.5% | $33.94M+4.2% | $32.58M-13.3% | $37.56M+5.3% | $35.67M-13.8% | ||
| -$282.21M-13.3% | -$249.07M-8.8% | -$228.87M-19.6% | -$191.31M-16.7% | -$163.91M-24.4% | ||
| —— | —— | —— | $56K— | $0— | ||
| -$622.25M-89.1% | -$329.04M-2,744% | -$11.57M— | —— | —— | ||
| $1.26B+79.1% | $702.17M+245% | $203.42M+2.7% | $198.1M-48.7% | $385.84M-25.0% | ||
| $370.77M+161% | $141.96M+843% | -$19.12M-256% | $12.27M-39.9% | $20.42M-85.5% | ||
| -$282.33M-13.3% | -$249.12M-8.8% | -$228.92M-19.6% | -$191.36M-16.7% | -$163.91M-24.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Praxis Precision Medicines, Inc. generate?
- Praxis Precision Medicines, Inc. (PRAX) generated -$282.2M in operating cash flow over the trailing twelve months.
- What is Praxis Precision Medicines, Inc.'s free cash flow?
- After $118.0K of capital expenditures, Praxis Precision Medicines, Inc.'s free cash flow was -$282.3M over the trailing twelve months, down 72.3% year over year.
- Where does Praxis Precision Medicines, Inc.'s cash flow data come from?
- Every line is extracted from Praxis Precision Medicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.